La catena delle opzioni mostra i dati chiave delle opzioni azionarie di LifeStance Health Gr a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per LifeStance Health Gr..

LifeStance Health Gr (NASDAQ:LFST) Azioni, Catena delle Opzioni

LifeStance Health Gr

LifeStance Health Group Inc is a mental healthcare company focused on providing evidence-based, medically driven treatment services for children, adolescents, and adults suffering from a variety of mental health issues in an outpatient care setting, both in-person and through its digital health telemedicine offering.

LifeStance Health Group

LifeStance Health Group, Inc. - Common Stock

LifeStance Health Group Inc

Citigroup analyst Christopher Danely maintains GLOBALFOUNDRIES (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GFS#NASDAQ">GFS</a>) with a Neutral and lowers the price target from $45 to $40.

News

Price Target

Analyst Ratings

Citigroup Maintains Neutral on GLOBALFOUNDRIES, Lowers Price Target to $40

NVIDIA Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) passed Apple, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) to become the world's largest publicly traded <a href="https://www.benzinga.com/news/24/11/41751557/nvidia-takes-short-lived-lead-over-apple-in-valuation">company on Tuesday. </a>
The Details: Nvidia ended Tuesday's trading session with a market capitalization of $3.43 trillion, slightly <a href="https://www.benzinga.com/news/24/11/41751557/nvidia-takes-short-lived-lead-over-apple-in-valuation">edging out </a>Apple&#8217;s $3.38 trillion valuation, according to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>. The semiconductor giant's dominance in the artificial intelligence chip market has fueled its exponential growth of more than 200% over the past year.&nbsp;
Read More: <a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/24/11/41724410/nvidia-joining-dow-jones-industrial-average-where-tech-giant-ranks-in-the-index-why-sh">Nvidia Joining Dow Jones Industrial Average: Where Tech Giant Ranks In The Index, Why Sherwin-Williams Addition Could Be More Important</a>
Nvidia briefly passed Apple <a href="https://www.benzinga.com/news/24/06/39386946/microsoft-apple-step-aside-nvidia-is-now-the-most-valuable-public-company-in-the-world">in market cap </a>in June before sliding over the summer.<a href="https://www.cnbc.com/quotes/MSFT/"> </a>Nvidia&#8217;s ascent to the top highlights the growing importance of AI technology and the pivotal role that Nvidia's specialized hardware plays in its development.&nbsp;
Despite Nvidia's remarkable growth over the past year, analysts remain bullish on the company's growth ahead. The three most recent analyst ratings were released by BofA Securities, Goldman Sachs and Morgan Stanley in October with an average price target of $163.33 between the three. There&#8217;s an implied 17.04% upside for Nvidia stock from these analyst ratings.
Last Friday, S&amp;P Dow Jones announced that Nvidia <a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/24/11/41724410/nvidia-joining-dow-jones-industrial-average-where-tech-giant-ranks-in-the-index-why-sh">is joining the Dow Jones Industrial Average on Nov. 8 </a>replacing Intel Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) and joining Apple in the blue-chip index. 
NVDA Price Action: According to data from Benzinga Pro, Nvidia shares ended Tuesday's session 2.84% higher at $139.91.&nbsp;
Read Also:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41690154/shock-october-jobs-report-leaves-fed-in-tight-spot-experts-say-interest-rate-cuts-a">Shock October Jobs Report Leaves Fed In &#8216;Tight Spot:&#8217; Experts Say Interest Rate Cuts Ahead</a></li>
</ul>
Image: Shutterstock

Large Cap

Movers

Tech

AAPL

INTC

NVDA

Nvidia Blows Past Apple To Become World's Most Valuable Company

Lake Street analyst Mark Argento maintains Gaia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GAIA#NASDAQ">GAIA</a>) with a Buy and raises the price target from $6 to $7.

GAIA

Lake Street Maintains Buy on Gaia, Raises Price Target to $7

Lake Street analyst Thomas Flaten maintains Castle Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSTL#NASDAQ">CSTL</a>) with a Buy and raises the price target from $34 to $40.

CSTL

Lake Street Maintains Buy on Castle Biosciences, Raises Price Target to $40

Lake Street analyst Jaeson Schmidt maintains NAPCO Security Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NSSC#NASDAQ">NSSC</a>) with a Buy and lowers the price target from $60 to $41.

NSSC

Lake Street Maintains Buy on NAPCO Security Techs, Lowers Price Target to $41

Gulf Island Fabrication (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GIFI#NASDAQ">GIFI</a>) .

Guidance

GIFI

Gulf Island Fabrication expect FY2024 adjusted consolidated EBITDA of $11M-$13M.

Lake Street analyst Eric Martinuzzi maintains QuinStreet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QNST#NASDAQ">QNST</a>) with a Hold and raises the price target from $20 to $25.

QNST

Lake Street Maintains Hold on QuinStreet, Raises Price Target to $25

Syndax Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDX#NASDAQ">SNDX</a>) .

SNDX

Syndax Pharmaceuticals FY2024 R&D expenses forecast: $245M-$250M.

Loop Capital analyst Rob Sanderson maintains Snap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNAP#NYSE">SNAP</a>) with a Buy and raises the price target from $14 to $16.

SNAP

Loop Capital Maintains Buy on Snap, Raises Price Target to $16

Gulfport Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPOR#NYSE">GPOR</a>) .

GPOR

Gulfport Energy Full Year 2024: Drilling and completion capex guidance cut to $325M-$335M.

Loop Capital analyst Garik Shmois maintains Knife River Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KNF#NYSE">KNF</a>) with a Buy and lowers the price target from $105 to $100.

Loop Capital Maintains Buy on Knife River Holding, Lowers Price Target to $100

Barclays analyst Blayne Curtis maintains NXP Semiconductors (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXPI#NASDAQ">NXPI</a>) with a Overweight and lowers the price target from $330 to $280.

NXPI

Barclays Maintains Overweight on NXP Semiconductors, Lowers Price Target to $280

It's Election day! Voters are visiting polling locations and social media mavens are sharing opinions and local reports in megathreads, polls and comments on Reddit Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>).
Here are some notable threads to follow for election <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41631795/reddit-remains-a-favorite-for-wall-street-after-emphatic-beat-and-raise-in-q3">coverage on Reddit.&nbsp;</a>
Polls Open: Subreddit r/politics has over 8.5 million subscribers and features a <a href="https://www.reddit.com/r/politics/comments/1gkefi6/rpolitics_2024_us_elections_live_thread_part_59/">live thread</a> with 59 parts titled, "2024 US Elections Live Thread, Part 59" which contains more than 3,200 comments, voter turnout reports from different locations and live commentary on election developments.&nbsp;
Subreddit r/moderatepolitics has 295,000 members and a <a href="https://www.reddit.com/r/moderatepolitics/">poll titled</a> "Who are you voting for in the 2024 US Presidential Election." At the time of publication, 2,100 Redditors selected Harris, 1,300 selected Trump, 301 selected Other and 842 responded with Not Voting.&nbsp;
Read Next: <a href="https://www.benzinga.com/news/earnings/24/10/41612293/reddit-stock-soars-after-strong-q3-results-q4-guidance-above-estimates-dauqs-grow-17-and-more">Reddit Stock Soars After Strong Q3 Results, Q4 Guidance Above Estimates: DAUq&#8217;s Grow 17% And More</a>
Reddit also features local subreddits like r/Pennsylvania, which has <a href="https://www.reddit.com/r/Pennsylvania/comments/1gjutyd/the_election_day_mega_thread/">a thread</a> titled, "The Election Day Mega Thread" where users can find coverage of the crucial swing state and voting guides and polling locations. The thread also provides local polling updates and news with first-hand accounts from voters across the state.&nbsp;
Where To Find Results: FiveThirtyEight, the data journalism outlet, will feature county-by-county data breakdowns as the polling results come in at its r/fivethirtyeight <a href="https://www.reddit.com/r/fivethirtyeight/">subreddit</a>. It also features discussions about polling accuracy and several live election megathreads.&nbsp;&nbsp;
The r/Journalism <a href="https://www.reddit.com/r/Journalism/">subreddit</a> will provide authoritative sources for results, including updates from the Associated Press and major networks, as well as discussions about result reporting methodology.&nbsp;
Reddit&#8217;s election coverage offers a blend of real-time updates and community engagement across various specialized subreddits, though most users recommend keeping multiple sources open for the most complete picture.&nbsp;
RDDT Price Action: According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Reddit shares ended Tuesday&#8217;s session 12.42% higher at $122.57.
Read Also:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/24/11/41685913/jpmorgan-to-pay-investors-151-million-after-sec-flags-various-law-violations">JPMorgan To Pay Investors $151 Million After SEC Flags &#8216;Various Law Violations&#8217;</a></li>
</ul>
Photo: Shutterstock

Social Media

Politics

General

RDDT

Redditors Track Election Night: Must-Watch Threads For Trump Vs. Harris Showdown, Other Races

WIIM

WillScot Holdings shares are trading higher following a report suggesting activist investor TOMS has built a stake in the company and is pushing for a review.

JP Morgan analyst Kevin Yin upgrades Yum China Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUMC#NYSE">YUMC</a>) from Neutral to Overweight and raises the price target from $35.5 to $60.

Upgrades

YUMC

JP Morgan Upgrades Yum China Holdings to Overweight, Raises Price Target to $60

With the first polling places about to close in what is <a href="https://www.benzinga.com/general/politics/24/11/41748843/trump-holds-edge-in-betting-markets-on-election-day-while-experts-call-tight-race-for-harris">expected to be a neck-and-neck election night</a>, reports from Georgia and Michigan say those two swing states are seeing record-high turnout.
What Happened: Turnout in Philadelphia is also reported to be extremely high, with Reuters reporting turnout as much as 50% higher in some precincts than in 2020. A big win in Philadelphia would go a long way toward delivering Pennsylvania &#8211; the largest and tightest swing state &#8211; to Kamala Harris.
At 4:39 p.m. EDT, Donald Trump wrote on Truth Social: &#8220;A lot of talk about massive CHEATING in Philadelphia. Law Enforcement coming!!!&#8221; 
A Philadelphia police spokesman <a href="https://fortune.com/2024/11/05/donald-trump-claims-cheating-police-philadelphia-pennsylvania/">told Fortune</a> they are &#8220;not aware of anything at this time.&#8221; 
Charlie Kirk of pro-Trump group Turning Point Action wrote earlier on X: &#8220;Turnout is mixed and not where we want it to be. We need more people to vote.&#8221;
Also Read: <a href="https://www.benzinga.com/general/politics/24/11/41725742/2024-election-stakes-potential-sweeps-split-outcomes-in-congressional-presidential-races">2024 Election Stakes: Potential Sweeps, Split Outcomes In Congressional, Presidential Races</a>
Politico is <a href="https://www.politico.com/live-updates/2024/11/05/2024-elections-live-coverage-updates-analysis/turnout-high-in-georgia-00187458">reporting</a> that turnout in Georgia is on track to surpass 2020, and The Hill <a href="https://thehill.com/homenews/campaign/4973132-michigan-on-pace-to-break-voter-turnout-records-official-says/">says</a> that Michigan may break turnout records.
Why It Matters: High turnout in Philadelphia would be good news for Harris, but even a loss in Pennsylvania would not be fatal to Trump if he performs well in other swing states.
Georgia, Michigan and Pennsylvania were all key to Joe Biden&#8216;s victory in 2020.
Read Next
<ul>
<li><a href="https://www.benzinga.com/general/politics/24/11/41728436/trump-vs-harris-2024-election-deadlocked-final-emerson-poll-shows-one-candidate-with-small-edge-">Trump Vs. Harris: 2024 Election Deadlocked, Final Emerson Poll Shows One Candidate With Small Edge Among Independents</a></li>
</ul>
Image: Shutterstock.

High Turnout Reported In Key States, Trump Baselessly Alleges 'Massive CHEATING' In Philadelphia

A new study <a href="https://tandfonline.com/doi/full/10.1080/21507740.2024.2303154">published</a> in AJOB Neuroscience reveals that most Americans are supportive of <a href="https://www.benzinga.com/topic/psilocybin">psilocybin</a> use, a psychedelic compound derived from "magic mushrooms," in supervised, licensed settings. As PsyPost <a href="https://www.psypost.org/majority-of-americans-support-supervised-use-of-psilocybin-for-mental-health-and-well-being/">reported</a>, this approval, spanning across political lines, underscores public openness to the controlled use of <a href="https://www.benzinga.com/topic/psychedelic-assisted-therapies">psilocybin for mental health treatment</a> and general well-being, despite remaining concerns for policy caution.
Psilocybin, a <a href="https://www.benzinga.com/topic/federal-schedule-i">Schedule 1</a> drug in the U.S., has long been classified as having a high potential for abuse with no accepted medical use. However, <a href="https://www.benzinga.com/markets/cannabis/24/10/41216395/could-psilocybin-be-a-game-changer-for-millions-battling-depression-new-study-says-yes">recent clinical studies</a> suggest it may help alleviate symptoms of conditions such as treatment-resistant depression when administered under professional supervision. Unlike many medications, psilocybin is considered non-addictive, and studies have found it may also <a href="https://www.benzinga.com/markets/cannabis/24/09/41004196/psilocybin-found-to-be-as-effective-as-lexapro-in-treating-depression-researchers-say">enhance overall well-being</a> in healthy individuals.
This research aimed to explore public perceptions of psilocybin amid <a href="https://www.benzinga.com/markets/cannabis/24/08/40447902/psychedelics-and-mental-health-fda-stalls-but-states-forge-ahead">recent legislative progress</a>, such as Oregon&#8217;s law <a href="https://www.benzinga.com/markets/cannabis/20/11/18204455/oregon-becomes-first-us-state-to-decriminalize-drug-possession-begins-psilocybin-program">allowing its therapeutic use</a>. Researchers surveyed 805 Americans, aged 18 to 92, providing background on psilocybin's effects, origin and legal status before asking about support for nationwide legalization.
<h3 class="wp-block-heading">Mental Health Treatment Vs. Well-Being Enhancement</h3>
Participants were presented with two scenarios involving supervised psilocybin use: one for mental health treatment and the other for personal well-being. A strong 89% of participants supported psilocybin use for mental health treatment, while 85% approved its use for well-being enhancement. Though medical use garnered slightly more support, both scenarios saw broad endorsement.
The results show bipartisan support for supervised psychedelic therapy, with younger and more liberal adults showing stronger approval. Older adults and conservatives were more cautious, while those valuing empathy and care were more supportive of psilocybin use in therapy
<h3 class="wp-block-heading">Navigating Caution Amid The Psychedelic Renaissance</h3>
The study also sheds light on the importance of tempering enthusiasm with scientific rigor. According to the researchers, the growing interest in psychedelics comes with the risk of overhyping benefits. Given the early stage of the field, both over- and understatements of trial results are not uncommon. As they noted, while psilocybin shows significant medical potential and a strong safety profile, current evidence doesn&#8217;t support rash conclusions beyond its use in the right context.
While the findings suggest broad public support for supervised psychedelic use, the study focused only on licensed environments, excluding unsupervised or recreational use. Future research could explore attitudes toward these higher-risk aspects.
<h3 class="wp-block-heading">Building Trust And Policy For The Future</h3>
The study authors stressed the need for trust-building and caution in shaping future policies. "If the field can overcome scientific inaccuracies, pursue rigorous research, and build trust—then psychedelics such as psilocybin may one day be seen as a mainstream means to treat mental illness and possibly also to promote overall well-being," they concluded.
With public support reaching bipartisan levels, the potential for psilocybin to become part of standard mental health care is closer to reality than ever, signaling a transformative shift in mental health treatment in the U.S.
Cover image made with AI

Cannabis

Psychedelics

Americans Favor Psilocybin For Mental Health Treatment, Study Finds

DA Davidson analyst Brian Holland maintains Freshpet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) with a Buy and raises the price target from $183 to $189.

FRPT

DA Davidson Maintains Buy on Freshpet, Raises Price Target to $189

Hut 8 Says Its Self-Mining Produced 100 BTC In October, Up From 85 BTC In September; Vega Site Buildout Advancing On Track For Q2 2025 Energization

DA Davidson analyst Michael Shlisky maintains Federal Signal (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FSS#NYSE">FSS</a>) with a Neutral and lowers the price target from $94 to $90.

DA Davidson Maintains Neutral on Federal Signal, Lowers Price Target to $90

Lifestance Health Group (LFST) has shared an update. Danish Qureshi's tenure as President and COO of LifeStance Health Group ended on June 30, 2024...

LifeStance Health Group Finalizes Executive Separation Terms

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Investing in low-cost <a href="https://investorplace.com/stock-types/growth-stocks/">growth stocks</a> requires understanding the underlying companies&rsquo; fundamentals. Monitoring the core metrics and operational strengths is vital to assessing a company&rsquo;s long-term viability and growth potential. 



Take, for instance, the first company, which&nbsp;shows remarkable improvement in credit performance with a notable reduction in its net charge-off rate. Meanwhile, the second company successfully exceeds its cost reduction targets. It significantly lowered operating expenses and boosted profitability through strategic restructuring. The third company on our list demonstrates exceptional capital management. It uses debt issuance strategically to boost cash flow and navigate market uncertainties. Moreover, the fourth company achieved its first profitability milestone, showcasing effective cost management and operational efficiency.&nbsp;



Similarly, the fifth stock listed here represents a company that significantly reduced production costs, increased operational efficiency and expanded reserves. The sixth company maintained its top position in its field by attaining high top-line growth and improved profitability through sharp cost management and market penetration. Finally, the seventh company demonstrates impressive financial performance and operational improvements.



In short, each of these low-cost growth stocks represents a company with unique fundamentals, making them compelling choices for potential high returns.



<h2>OppFi (OPFI)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/01/creditcards1600-300x169.jpg" alt="a pile of credit cards, credit card interest rates"><div>Source: Teerasak Ladnongkhun/Shutterstock.com</div></div>OppFi (NYSE:<a href="https://investorplace.com/stock-quotes/opfi-stock-quote/">OPFI</a>) specializes in credit performance and financial services. It achieved a&nbsp;<a href="https://s27.q4cdn.com/889956127/files/doc_financials/2024/q1/OppFi-Exceeds-First-Quarter-2024-Guidance-Raises-Full-Year-Earnings-Outlook-2024.pdf" target="_blank">1.1 percentage point&nbsp;</a>improvement in the net charge-off rate, which reduced the rate to 47.9% (in the first quarter),&nbsp;indicating reduced risk and improved credit quality. Effective credit risk management and underwriting processes help maintain financial stability. A&nbsp;<a href="https://s27.q4cdn.com/889956127/files/doc_financials/2024/q1/OppFi-Exceeds-First-Quarter-2024-Guidance-Raises-Full-Year-Earnings-Outlook-2024.pdf" target="_blank">33.5% increase&nbsp;</a>in recoveries further shows improved credit performance. Recovering more from previously charged-off loans mitigates loan defaults&rsquo; impact.



Moreover, early-stage delinquency rates also improved significantly. The first payment default rate decreased by 0.4%. The total&nbsp;<a href="https://finance.yahoo.com/news/oppfi-inc-nyse-opfi-q1-142244972.html" target="_blank">delinquency rate fell by 0.7%</a>&nbsp;compared to last year. These improvements signify stronger credit quality and better customer payment behavior. Lower delinquency rates suggest effective credit risk assessment models. Stronger customer payment behavior supports sustainable revenue and profitability growth.



Finally, OppFi is noted for improved credit quality and risk management, making it a standout in low-cost growth stocks.



<h2>Pitney Bowes (PBI)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/08/pbi-stock-1-300x169.jpg" alt="The office logo for Pitney Bowes on a glass building."><div>Source: JHVEPhoto / Shutterstock.com</div></div>Pitney Bowes (NYSE:<a href="https://investorplace.com/stock-quotes/p%EF%BF%BCbi-stock-quote/">PBI</a>) excels in providing in-office services and supplies and focuses on cost reduction and operational efficiency. The company improved its financial performance significantly. It has exceeded its cost savings target of&nbsp;<a href="https://www.investorrelations.pitneybowes.com/static-files/36e2c1cf-38dc-4a9c-9da3-890a5b116d33" target="_blank">$75 million to $85 million in the first quarter</a>. The restructuring plan&rsquo;s success is evident in cost savings and expense decline. Pitney Bowes now expects to surpass the high end of this target.



Operating expenses dropped 8% year-over-year from a year ago, enhancing financial health. Segment performance shows strong growth potential, with key segments including SendTech, presort services and global e-commerce.



Further, SendTech&rsquo;s earnings before interest and taxes, or EBIT, grew 6% to&nbsp;<a href="https://www.investorrelations.pitneybowes.com/static-files/36e2c1cf-38dc-4a9c-9da3-890a5b116d33" target="_blank">$101 million</a>&nbsp;despite a 2% revenue decline. Shipping-related revenue grew 8%. Software-as-a-service (SaaS) subscription revenue increased by 40%, showing strong growth potential. Presort services achieved record revenue and EBIT. Revenue rose 7% to $170 million, while EBIT&nbsp;<a href="https://www.investorrelations.pitneybowes.com/static-files/df23e5e4-0068-4cb3-a4d9-938d92ccca39" target="_blank">reached $40 million</a>. 



Overall, successful restructuring and cost-saving measures position Pitney Bowes as a strong candidate among low-cost growth stocks.



<h2>Garrett Motion (GTX)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/auto1600-300x169.jpg" alt="a front view shot of a white sports car on the highway during daytime"><div>Source: Shutterstock</div></div>The technology leader Garrett Motion (NASDAQ:<a href="https://investorplace.com/stock-quotes/gtx-stock-quote/">GTX</a>) manufactures automotive parts and equipment. Garrett issued&nbsp;<a href="https://investors.garrettmotion.com/node/11641/pdf" target="_blank">$800 million</a>&nbsp;in senior unsecured notes in the second quarter. This move generates annual cash interest savings of $15 million. Reduced debt and interest expenses improve financial stability.



In the second quarter, Garrett repurchased $65 million of common stock. The total repurchased in the first half of 2024 <a href="https://seekingalpha.com/article/4706607-garrett-motion-inc-gtx-q2-2024-earnings-call-transcript" target="_blank">reached $174 million</a>. This strategy signals confidence in future growth prospects. The company ended the quarter with&nbsp;solid&nbsp;liquidity of $698 million. This&nbsp;includes $600 million of undrawn revolving credit and $98 million of unrestricted cash.



Additionally, Garrett has ample financial flexibility for economic uncertainties and growth opportunities. Its strength is adapting its cost structure to industry volatility. Garrett offset reduced sales through operational productivity and cost control. The adjusted EBITDA margin remained&nbsp;<a href="https://investors.garrettmotion.com/node/11641/pdf" target="_blank">resilient at 16.9%</a>&nbsp;despite a 12% drop in net sales.



In summary, effective capital management and share repurchase strategies enhance its appeal, making it a top pick among low-cost growth stocks.



<h2>Tuniu (TOUR)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/06/travel-stocks-1600-300x169.jpg" alt="A photo of an excited woman riding on the back of a bike a man is driving."><div>Source: OPOLJA / Shutterstock.com</div></div>The online leisure travel company Tuniu (NASDAQ:<a href="https://investorplace.com/stock-quotes/tour-stock-quote/">TOUR</a>) is based in China provides hospitality services, including hotels, resorts, and cruise lines. Tuniu achieved GAAP profitability in the first quarter. The company reported net income of&nbsp;<a href="https://filecache.investorroom.com/mr5ir_tuniu/202/Tuniu%20Announces%20Unaudited%20First%20Quarter%202024%20Financial%20Results.pdf" target="_blank">RMB 22 million</a> ($3.03 million),&nbsp;which marks a significant milestone for Tuniu. Last year, the company had a loss of RMB 5.9 million.



Operating expenses increased by&nbsp;<a href="https://filecache.investorroom.com/mr5ir_tuniu/202/Tuniu%20Announces%20Unaudited%20First%20Quarter%202024%20Financial%20Results.pdf" target="_blank">25% from a year ago to RMB 69.7 million</a>. The proportion of operating expenses relative to net revenues decreased significantly.&nbsp;



Moreover, total operating expenses as a percentage of net revenues dropped by 20 percentage points. Indeed, this decline indicates improved operational efficiency. Research expenses decreased by 9% to RMB 13 million. Research and development costs as a percentage of net revenues dropped from&nbsp;<a href="https://finance.yahoo.com/news/tuniu-corporation-nasdaq-tour-q1-120241361.html" target="_blank">22.7% to 12.1%</a>, indicating Tuniu&rsquo;s efficient resource allocation. The company&rsquo;s cost-control measures in research are effective.



Finally, Tuniu&rsquo;s recent profitability and improved efficiency contribute to its selection on the low-cost growth stocks list.



<h2>Nexa Resources (NEXA)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/02/precious-metals-1600-300x169.jpg" alt="Close-up of a gold-ingot on top of a troy ounce silver and palladium bar. Precious metals. Gold, silver, palladium. materials stocks. resource shortage stocks"><div>Source: corlaffra / Shutterstock</div></div>Nexa Resources (NYSE:<a href="https://investorplace.com/stock-quotes/nexa-stock-quote/">NEXA</a>) is a diversified metals and mining company in Brazil. In the first quarter, metal sales totaled&nbsp;<a href="https://www.nexaresources.com/en/nexa-resources-delivers-solid-operating-performance-in-1q24/" target="_blank">139,000 metric tons</a>. This&nbsp;marked a 4% year-over-year decline, caused by lower production volumes and seasonal demand. Additionally, the cost of smelting cash fell to 98 cents per pound, a 22% decrease from $1.25 per pound a year ago. Lower raw material costs and decreased zinc prices drove this reduction. Conversion costs were&nbsp;<a href="https://finance.yahoo.com/news/nexa-resources-nyse-nexa-q1-142029857.html" target="_blank">30 cents per pound</a>, down from 31 cents a year ago. Hence, lower variable and energy costs contributed to this decrease.&nbsp;



Further, capacity utilization for the company&rsquo;s Aripuan&atilde;&rsquo;s mine increased to&nbsp;<a href="https://finance.yahoo.com/news/nexa-resources-nyse-nexa-q1-142029857.html" target="_blank">70% in April&nbsp;</a>from 57% in Q1 2024. Zinc recovery improved to 73% in March from 66% in December 2023. The company&rsquo;s Cerro de Pasco project has a sharp 59% increase in mineral reserves.



Nexa&rsquo;s overall mineral reserves grew 10% in 2023 against 2022. Moreover, progressive exploration and drilling activities boosted reserves. In short, improved cost efficiencies and enhanced production make Nexa a top pick among low-cost growth stocks.



<h2>High Tide (HITI)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/02/medical-marijuana-cannabis-300x169.png" alt="An image of different forms of medical marijuana"><div>Source: Bukhta Yurii/Shutterstock</div></div>High Tide (NASDAQ:<a href="https://investorplace.com/stock-quotes/hiti-stock-quote/">HITI</a>) is a Canadian cannabis company that operates in the pharmaceuticals sector, focusing on drug development and distribution. In the second quarter, High Tide recorded <a href="https://hightideinc.com/high-tide-reports-second-quarter-2024-financial-results-featuring-record-free-cash-flow-of-9-4-million-and-positive-net-income/" target="_blank">$124.3 million in revenue</a>, marking a 5% increase from a year ago. The company surpassed $500 million in trailing 12-month revenue. With that, High Tide, Canada&rsquo;s highest revenue-generating cannabis company, maintained this lead for almost two years.



Additionally, the company&rsquo;s core brick-and-mortar segment grew by 11% from a year ago, accounting for 93% of the company&rsquo;s&nbsp;top line.&nbsp;This outperforms peers, who&nbsp;<a href="https://seekingalpha.com/article/4699347-high-tide-inc-hiti-q2-2024-earnings-call-transcript" target="_blank">average $923,000</a>.



High Tide&rsquo;s average Ontario store had a $3.4 million annual revenue&nbsp;run rate. The gross profit for the quarter was $35.3 million (up 12% from year ago. The gross profit margin improved to 28.4%, which was the highest in nine quarters.



Indeed, High Tide&rsquo;s financial stability and cost management highlight its growth potential, standing out in the low-cost growth stocks category.



<h2>Lifestance Health (LFST)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/09/telehealth_1600_b-300x169.jpg" alt="A woman talks to a doctor on her laptop. telehealth stocks"><div>Source: fizkes/ShutterStock.com</div></div>Lifestance Health (NASDAQ:<a href="https://investorplace.com/stock-quotes/lfst-stock-quote/">LFST</a>) offers mental health services in a telemedicine format. The company&rsquo;s bottom line&nbsp;is solid. Adjusted EBITDA for&nbsp;the first quarter <a href="https://investor.lifestance.com/node/9066/pdf" target="_blank">was $27.7 million</a>, a massive 174% increase from the previous year&rsquo;s $10.1 million. The adjusted EBITDA margin improved to 9.2%, up from 4% in Q1 2023. This growth is due to higher revenue per visit. Enhanced operating leverage also played a key role.



Moreover, the company scaled efficiently while controlling costs. LifeStance achieved a 36% increase in center margin, which reached $94.7 million, or 31.5% of total revenue. The center margin as a percentage of revenue grew nearly <a href="https://investor.lifestance.com/node/9066/pdf">4 percentage points</a> year over year,&nbsp;reflecting effective cost management and operational efficiencies.&nbsp;



Indeed, the increase in the center margin indicates improved profitability. Real estate optimization and operating leverage drove this improvement. Efficiently managing center costs and&nbsp;<a href="https://investor.lifestance.com/static-files/53934f14-4039-478b-a556-319fc5e966e8" target="_blank">higher revenue per visit&nbsp;</a>contributed to this success. LifeStance has shown it can scale operations profitably. Strong financial performance and operational improvements make it a top pick among low-cost growth stocks.



On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, Yiannis Zourmpanos did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines.</a>



On the date of publication, the responsible editor did not have (either directly or indirectly) any positions in the securities mentioned in this article.
<div>Yiannis Zourmpanos is the founder of Yiazou Capital Research, a stock-market research platform designed to elevate the due diligence process through in-depth business analysis.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>
The post <a href="https://investorplace.com/2024/08/7-low-cost-stocks-with-unexpected-growth-potential/">7 Low-Cost Stocks With Unexpected Growth Potential</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

7 Low-Cost Stocks With Unexpected Growth Potential

LifeStance Health Group GAAP EPS of -$0.06, revenue of $312.3M

Goldman Sachs analyst Jamie Perse has maintained their bullish stance on LFST stock, giving a Buy rating on July 23. Jamie Perse has given his Buy ...

Robust Growth and Strong Financials Drive Buy Rating for Lifestance Health Group

LifeStance Health Group, Inc. 2024 Q2 - Results - Earnings Call Presentation

LifeStance Health Group, Inc. (LFST) Q2 2024 Earnings Call Transcript

Barclays analyst Stephanie Davis maintained a Sell rating on Lifestance Health Group (LFST – Research Report) today and set a price target of $6.00...

Barclays Sticks to Their Sell Rating for Lifestance Health Group (LFST)

Morgan Stanley's 20 Top Stock Picks

LifeStance Health Group: Long-Term Growth With Adj. EBITDA Margin Inflection Upwards

In a report released today, Craig Hettenbach from Morgan Stanley maintained a Buy rating on Lifestance Health Group (LFST – Research Report), with ...

Lifestance Health Group: A Strong Buy on Accessible Mental Healthcare and Market Positioning

CMCSA

DKNG

FTAI

HITI

LFST

NDAQ

NEXA

NTRA

OPFI

SPOT

TOST

TOUR

TSLA

Health Care

Press Releases

LifeStance Health Group Announces Launch of Secondary Public Offering

IPOs

LifeStance Health Group Announces Pricing of Secondary Public Offering

LifeStance to Participate in Upcoming Investor Conferences

LifeStance to Host Second Quarter 2024 Earnings Conference Call on August 8, 2024

LifeStance Survey Finds US Adults Prioritize Access to Therapy Over Free Taylor Swift Tickets and Vacations

Earnings

LifeStance Reports Second Quarter 2024 Results

Legal

Bragar Eagel & Squire, P.C. Is Investigating LifeStance and Customers Bancorp and Encourages Investors to Contact the Firm

LifeStance to Present at the 22nd Annual Morgan Stanley Healthcare Conference

LifeStance Survey Finds 79% of Americans Are Experiencing Anxiety Over the 2024 U.S. Presidential Election

LifeStance to Host Third Quarter 2024 Earnings Conference Call on November 7, 2024

CUBI

Addus HomeCare Corporation - Common Stock

Addus HomeCare

Agilon Health

Amedisys

AMN Healthcare Services

Astrana Health

BrightSpring Health Services, Inc. - Common Stock

BrightSpring Health

Chemed

Cigna

CorVel

CVS Health

Quest Diagnostics Incorporated Common Stock

Quest Diagnostics

DaVita

Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share)

Comments

LifeStance Health Gr

LifeStance Health Gr (LFST) Opzioni

LifeStance Health Gr (NASDAQ:LFST) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO